semaglutide vs tirzepatide efficacy weight loss oral cardiovascular outcomes soul trial results 2024 2025 Trial Scorecard: SOUL The SOUL Study - by

GLP-1 agonists have mixed cardiovascular effects

Tirzepatide is FDAapproved for specific indications, including type 2 diabetes and, at certain doses and brand names, chronic weight management in adults with defined BMI criteria plus at least one weight-related condition, when combined with lifestyle change

My Approach: Part of a Comprehensive Functional Medicine Framework I want to be clear about how GLP-1 medications fit into my practice, because context matters

Each group consisted of three mice

A doctor must evaluate your specific IBS subtype, overall health, and the medication's intended purpose (e.g., for diabetes) against the potential risks of worsened GI symptoms